【24h】

Quantitative estimation of antioxidant therapy efficiency in diabetes mellitus patients

机译:糖尿病患者抗氧化治疗效率的定量估计

获取原文
获取原文并翻译 | 示例

摘要

The aim of this work was to find out to which degree Tanakan affects the microcirculation parameters and the malonic dialdehyde level as a parameter of intense lipid peroxidation in insulin-independent diabetes patients with different disease durations. We used computerized capillaroscope GY-0.04 designed by the Centre for Analysis of Substances, Russia for the non-invasive measurement of capillary blood velocity as well as the size of the perivascular zone and density of blood aggregates and lipid inclusions. The microcirculation parameters were studied in two groups of insulin-independent diabetes patients. The basic group included 58 patients (61+-9,0 years, disease duration 14,7+-7,8 years). The patients had late diabetic complications as retinopathy and nephropathy, neuropathy, confirmed by clinical and tool investigation. In this group we also studied the level of serum malonic dialdehyde, as a parameter of intense lipid peroxidation. The reference group included 31 patients (57+-1,3 years, disease duration 3,6+-0,6 years) with minimum diabetic complications. We show that Tanakan in daily dosage 120 mg for 2 months reduces the malonic dialdehyde level in the blood serum and the erythrocyte membranes of type II diabetes patients and improves the microcirculation parameters. There are correspondences between the density of lipid inclusions as determined with computerized capillaroscopy and the lipid exchange parameters as determined using a routing blood test. Thus, noninvasive blood lipid quantification is feasible and reliable.
机译:这项工作的目的是找出在不同疾病持续时间的非胰岛素依赖型糖尿病患者中,Tanakan在多大程度上影响微循环参数和丙二醛水平,作为强烈的脂质过氧化作用的参数。我们使用由俄罗斯物质分析中心设计的计算机毛细管镜GY-0.04进行毛细管血流速度,血管周区域的大小以及血凝集和脂质包裹体密度的无创测量。在两组非胰岛素依赖型糖尿病患者中研究了微循环参数。基础组包括58例患者(61 + -9,0岁,病程14.7 + -7,8岁)。临床和工具研究证实,患者患有糖尿病晚期并发症,如视网膜病变和肾病,神经病变。在这一组中,我们还研究了血清丙二醛的水平,作为强烈的脂质过氧化作用的参数。参比组包括31例糖尿病并发症最少的患者(57 + -1,3年,病程3,6 + -0,6年)。我们显示,Tanakan日剂量为120 mg,持续2个月可降低II型糖尿病患者的血清和红细胞膜中丙二醛的水平,并改善微循环参数。通过计算机毛细管镜检查确定的脂质包裹体密度与使用路由血液测试确定的脂质交换参数之间存在对应关系。因此,无创血脂定量是可行和可靠的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号